These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24211289)

  • 1. The liver breath! Breath volatile organic compounds for the diagnosis of liver disease.
    Khalid T; Richardson P; Probert CS
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):524-6. PubMed ID: 24211289
    [No Abstract]   [Full Text] [Related]  

  • 2. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis.
    Hanouneh IA; Zein NN; Cikach F; Dababneh L; Grove D; Alkhouri N; Lopez R; Dweik RA
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):516-23. PubMed ID: 24036050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Volatil biomarkers: a revolution?].
    Astier A
    Ann Pharm Fr; 2013 Jul; 71(4):201-2. PubMed ID: 23835017
    [No Abstract]   [Full Text] [Related]  

  • 4. Microextraction techniques in breath biomarker analysis.
    Miekisch W; Trefz P; Bergmann A; Schubert JK
    Bioanalysis; 2014 May; 6(9):1275-91. PubMed ID: 25077354
    [No Abstract]   [Full Text] [Related]  

  • 5. How can nanotechnology be applied to sensors for breath analysis?
    Kim ID
    Nanomedicine (Lond); 2017 Nov; 12(22):2695-2697. PubMed ID: 28960136
    [No Abstract]   [Full Text] [Related]  

  • 6. Volatile disease biomarkers in breath: a critique.
    Kwak J; Preti G
    Curr Pharm Biotechnol; 2011 Jul; 12(7):1067-74. PubMed ID: 21466456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recognition of David Smith's unique contributions to the field of breath analysis.
    Beauchamp J; Risby TH
    J Breath Res; 2014 Sep; 8(3):030201. PubMed ID: 25189283
    [No Abstract]   [Full Text] [Related]  

  • 8. Does mass spectrometric breath analysis detect Pseudomonas aeruginosa in cystic fibrosis?
    Pabary R; Huang J; Kumar S; Alton EW; Bush A; Hanna GB; Davies JC
    Eur Respir J; 2016 Mar; 47(3):994-7. PubMed ID: 26846826
    [No Abstract]   [Full Text] [Related]  

  • 9. Progress in the development of volatile exhaled breath signatures of lung cancer.
    Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
    Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of volatile organic compounds as biomarkers in breath analysis by different analytical techniques.
    Buszewski B; Grzywinski D; Ligor T; Stacewicz T; Bielecki Z; Wojtas J
    Bioanalysis; 2013 Sep; 5(18):2287-306. PubMed ID: 24053244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Driving progress in exhaled breath biomarkers: Breath Biopsy Conference 2019.
    Lawson J; Boyle B; Beauchamp J
    J Breath Res; 2020 Jul; 14(3):030202. PubMed ID: 32662449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical variation in the exhaled volatile organic compounds.
    Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H
    J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
    Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
    Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: breath analysis in inflammatory bowel diseases.
    Kurada S; Alkhouri N; Fiocchi C; Dweik R; Rieder F
    Aliment Pharmacol Ther; 2015 Feb; 41(4):329-41. PubMed ID: 25523187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending breath analysis to the cellular level: current thoughts on the human microbiome and the expression of organic compounds in the human exposome.
    Pleil JD; Miekisch W; Stiegel MA; Beauchamp J
    J Breath Res; 2014 Jun; 8(2):029001. PubMed ID: 24800639
    [No Abstract]   [Full Text] [Related]  

  • 17. A systematic review of breath analysis and detection of volatile organic compounds in COPD.
    Christiansen A; Davidsen JR; Titlestad I; Vestbo J; Baumbach J
    J Breath Res; 2016 Aug; 10(3):034002. PubMed ID: 27578038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls in the analysis of volatile breath biomarkers: suggested solutions and SIFT-MS quantification of single metabolites.
    Smith D; Spanel P
    J Breath Res; 2015 Apr; 9(2):022001. PubMed ID: 25830501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Mycobacterium tuberculosis using volatile biomarkers in culture and exhaled breath.
    Mellors TR; Nasir M; Franchina FA; Smolinska A; Blanchet L; Flynn JL; Tomko J; O'Malley M; Scanga CA; Lin PL; Wagner J; Hill JE
    J Breath Res; 2018 Oct; 13(1):016004. PubMed ID: 29910196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.